These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25875363)

  • 21. Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression.
    Messchendorp AL; Meijer E; Boertien WE; Engels GE; Casteleijn NF; Spithoven EM; Losekoot M; Burgerhof JGM; Peters DJM; Gansevoort RT;
    Kidney Int Rep; 2018 Mar; 3(2):291-301. PubMed ID: 29725632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease.
    Parikh CR; Dahl NK; Chapman AB; Bost JE; Edelstein CL; Comer DM; Zeltner R; Tian X; Grantham JJ; Somlo S
    Kidney Int; 2012 Apr; 81(8):784-90. PubMed ID: 22258321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
    Chapman AB; Bost JE; Torres VE; Guay-Woodford L; Bae KT; Landsittel D; Li J; King BF; Martin D; Wetzel LH; Lockhart ME; Harris PC; Moxey-Mims M; Flessner M; Bennett WM; Grantham JJ
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):479-86. PubMed ID: 22344503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease.
    Messchendorp AL; Spithoven EM; Casteleijn NF; Dam WA; van den Born J; Tonnis WF; Gaillard CAJM; Meijer E;
    BMC Nephrol; 2018 Dec; 19(1):368. PubMed ID: 30567514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Yu ASL; Shen C; Landsittel DP; Harris PC; Torres VE; Mrug M; Bae KT; Grantham JJ; Rahbari-Oskoui FF; Flessner MF; Bennett WM; Chapman AB;
    Kidney Int; 2018 Mar; 93(3):691-699. PubMed ID: 29290310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher beta-hydroxybutyrate ketone levels associated with a slower kidney function decline in ADPKD.
    Knol MGE; Bais T; Geertsema P; Connelly MA; Bakker SJL; Gansevoort RT; van Gastel MDA;
    Nephrol Dial Transplant; 2024 Apr; 39(5):838-847. PubMed ID: 37974030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL; Cadnapaphornchai MA; Chonchol MB; Schrier RW; Gitomer B
    Am J Nephrol; 2016; 44(3):171-8. PubMed ID: 27548646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Baseline Urinary Metabolic Biomarkers with ADPKD Severity in TAME-PKD Clinical Trial Participants.
    Hallows KR; Althouse AD; Li H; Saitta B; Abebe KZ; Bae KT; Miskulin DC; Perrone RD; Seliger SL; Watnick TJ
    Kidney360; 2021 May; 2(5):795-808. PubMed ID: 34316721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.
    Higashihara E; Yamamoto K; Kaname S; Okegawa T; Tanbo M; Yamaguchi T; Shigemori K; Miyazaki I; Yokoyama K; Nutahara K
    Clin Exp Nephrol; 2019 Jan; 23(1):100-111. PubMed ID: 30097754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease.
    Messchendorp AL; van Londen M; Taylor JM; de Borst MH; Navis G; Casteleijn NF; Gaillard CAJM; Bakker SJL; Gansevoort RT;
    Clin J Am Soc Nephrol; 2018 Nov; 13(11):1680-1692. PubMed ID: 30254028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALTERATIONS IN HISTIDINE METABOLISM IS A FEATURE OF EARLY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD).
    Chapman A; Chen P
    Trans Am Clin Climatol Assoc; 2024; 134():47-65. PubMed ID: 39135565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
    Kim K; Trott JF; Gao G; Chapman A; Weiss RH
    BMC Nephrol; 2019 Feb; 20(1):66. PubMed ID: 30803434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD.
    Bais T; Geertsema P; Knol MGE; van Gastel MDA; de Haas RJ; Meijer E; Gansevoort RT;
    Clin J Am Soc Nephrol; 2024 May; 19(5):591-601. PubMed ID: 38407866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
    Torres VE; Abebe KZ; Schrier RW; Perrone RD; Chapman AB; Yu AS; Braun WE; Steinman TI; Brosnahan G; Hogan MC; Rahbari FF; Grantham JJ; Bae KT; Moore CG; Flessner MF
    Kidney Int; 2017 Feb; 91(2):493-500. PubMed ID: 27993381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression.
    Pejchinovski M; Siwy J; Metzger J; Dakna M; Mischak H; Klein J; Jankowski V; Bae KT; Chapman AB; Kistler AD
    Nephrol Dial Transplant; 2017 Mar; 32(3):487-497. PubMed ID: 27382111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between urinary biomarkers and disease progression in adults with autosomal dominant polycystic kidney disease.
    Segarra-Medrano A; Martin M; Agraz I; Vilaprinyó M; Chamoun B; Jatem E; Molina M; Colàs-Campàs L; Garcia-Carrasco A; Roche S
    Clin Kidney J; 2020 Aug; 13(4):607-612. PubMed ID: 32905289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Body Fat and Organic Acid Anions Production Are Associated with Larger Kidney Size in ADPKD.
    Dos Santos Dutra A; Rodrigues FG; da Rocha DR; Vendramini LC; de Matos ACC; Heilberg IP
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208476
    [No Abstract]   [Full Text] [Related]  

  • 40. Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney Disease.
    Wang K; Zelnick LR; Chen Y; Hoofnagle AN; Watnick T; Seliger S; Kestenbaum B
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):80-88. PubMed ID: 31628117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.